These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 12542895

  • 21. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    Kacharava AG, Tertov VV, Orekhov AN.
    Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
    [Abstract] [Full Text] [Related]

  • 22. Serum level of IgG autoantibodies against oxidized low density lipoproteins and lag-phase of serum oxidation in coronary heart disease--inverse correlation.
    Bakalova R, Zhelev Z, Goudev A, Ribarov S, Nachev C.
    Gen Physiol Biophys; 1999 Mar; 18(1):87-97. PubMed ID: 10378123
    [Abstract] [Full Text] [Related]

  • 23. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
    Mudd JO, Borlaug BA, Johnston PV, Kral BG, Rouf R, Blumenthal RS, Kwiterovich PO.
    J Am Coll Cardiol; 2007 Oct 30; 50(18):1735-41. PubMed ID: 17964036
    [Abstract] [Full Text] [Related]

  • 24. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, Garg N, Sinha N.
    Indian Heart J; 2003 Oct 30; 55(3):234-40. PubMed ID: 14560932
    [Abstract] [Full Text] [Related]

  • 25. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
    Granér M, Kahri J, Nakano T, Sarna SJ, Nieminen MS, Syvänne M, Taskinen MR.
    Eur J Clin Invest; 2006 Nov 30; 36(11):764-70. PubMed ID: 17032343
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC.
    Clin Chim Acta; 2009 Aug 30; 406(1-2):113-8. PubMed ID: 19523463
    [Abstract] [Full Text] [Related]

  • 29. Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women.
    Dotevall A, Hulthe J, Rosengren A, Wiklund O, Wilhelmsen L.
    Clin Sci (Lond); 2001 Nov 30; 101(5):523-31. PubMed ID: 11672458
    [Abstract] [Full Text] [Related]

  • 30. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
    Tsimikas S, Brilakis ES, Lennon RJ, Miller ER, Witztum JL, McConnell JP, Kornman KS, Berger PB.
    J Lipid Res; 2007 Feb 30; 48(2):425-33. PubMed ID: 17093289
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Minimally modified electronegative LDL and its autoantibodies in acute and chronic coronary syndromes.
    Oliveira JA, Sevanian A, Rodrigues RJ, Apolinário E, Abdalla DS.
    Clin Biochem; 2006 Jul 30; 39(7):708-14. PubMed ID: 16782081
    [Abstract] [Full Text] [Related]

  • 33. The level of malondialdehyde-modified LDL and LDL immune complexes in patients with rheumatoid arthritis.
    Wang J, Hu B, Meng Y, Zhang C, Li K, Hui C.
    Clin Biochem; 2009 Sep 30; 42(13-14):1352-7. PubMed ID: 19501077
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Sarandol A, Sarandol E, Eker SS, Karaagac EU, Hizli BZ, Dirican M, Kirli S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1103-8. PubMed ID: 16716479
    [Abstract] [Full Text] [Related]

  • 36. Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis.
    Rontu R, Metso S, Jaakkola O, Nikkilä M, Jokela H, Lehtimäki T.
    Clin Chem Lab Med; 2005 Aug 30; 43(4):357-60. PubMed ID: 15899649
    [Abstract] [Full Text] [Related]

  • 37. Differences in human antioxidized LDL autoantibodies in patients with stable and unstable angina.
    Fernandes JL, Orford JL, Garcia C, Coelho OR, Gidlund M, Blotta MH.
    J Autoimmun; 2004 Dec 30; 23(4):345-52. PubMed ID: 15571928
    [Abstract] [Full Text] [Related]

  • 38. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I, Benderly M, Sidi R, Boyko V, Tenenbaum A, Tanne D, Behar S.
    Am J Cardiol; 2009 Jan 01; 103(1):41-5. PubMed ID: 19101227
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
    Barbagallo CM, Rizzo M, Noto D, Frasheri A, Pernice V, Rubino A, Pieri D, Pinto V, Cefalù AB, Giordano C, Notarbartolo A, Averna MR.
    Metabolism; 2006 May 01; 55(5):662-8. PubMed ID: 16631444
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.